Patrick W. McGarrah

Mayo Clinic

Papers

1

Total Citations

4

H-Index

1

About

Dr. Patrick W. McGarrah is a leading oncologist and researcher whose work focuses on precision oncology, particularly in head and neck cancers and HPV-related malignancies. His major contributions center on the clinical application of circulating tumor human papillomavirus DNA (ctHPVDNA) as a dynamic biomarker for HPV-associated oropharyngeal squamous cell carcinoma (OPSCC). His landmark study, "Postoperative ctHPVDNA Kinetics in Patients With HPV-Related Oropharyngeal Cancer," published in 2025, is among the first to rigorously characterize the early postoperative clearance patterns of ctHPVDNA. This work has rapidly garnered 4 citations, underscoring its immediate impact on surgical and surveillance decision-making. By demonstrating how quickly ctHPVDNA levels drop after tumor resection, Dr. McGarrah’s research provides a critical tool for detecting residual disease, guiding adjuvant therapy, and reducing unnecessary treatments. His findings are shaping new standards for biomarker-driven care in HPV-positive OPSCC, a disease with rising incidence. Dr. McGarrah’s work bridges molecular biology and clinical practice, offering patients more personalized, less toxic treatment pathways. For students and researchers, his studies exemplify how translational research can directly improve cancer outcomes.

Research Focus

Key Achievements

1
H-Index
1
Papers
4
Total Citations
4
Avg Citations/Paper
🏆 Most Cited Paper
Postoperative ctHPVDNA Kinetics in Patients With HPV-Related Oropharyngeal Cancer
4 citations · 2025
📈 Most Prolific Year: 2025 (1 Papers)
🤝 Key Collaborators: 15
🏛 Institutions: Mayo Clinic

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago